[Bronchial arterial infusion chemotherapy in the treatment of stage III non-small cell lung cancer].
To explore the methods of comprehensive treatment of stage III non-small cell lung cancer ( NSCLC) . Treating group consisting of fifty patients with stage III NSCLC was treated with interventional chemotherapy, surgical treatment and radiotherapy, and 42 patients as control. Resection rate in treating group was 94. 0% after interventional chemotherapy, and 84. 0% of the group got radical resection. The 1-, 3-, 5-year survival rates were 44. 0%, 36. 0%, and 22. 0% in the treating group, and were 23. 8%, 16. 7% and 7. 1% respectively in control group ( P < 0. 05) . Standard comprehensive treatment is helpful to improve curative effect of stage III NSCLC.